
Arrowhead Pharmaceuticals, Inc.
ARWRHealthcare|Biotechnology|US
$58.16
+0.70 (+1.22%)
Tangible Book / Share
$3.21
Cash / Share
$11.17
Ownership Breakdown
86.7%
Float
141.3M
Shares Outstanding
122.4M
Float Shares
Major Holders (8)
Combined: 56.8%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| BlackRock, Inc. | Holding company | 10.10% | 14,232,545 | Jul 27, 2026 | 13D/G |
| Avoro Capital Advisors LLC | IA, OO | 9.64% | 13,823,383 | Aug 14, 2026 | 13D/G |
| Behzad Aghazadeh | HC, IN | 9.64% | 13,823,383 | Aug 14, 2026 | 13D/G |
| FMR LLC | Holding company | 6.60% | 9,307,349 | Nov 5, 2026 | 13D/G |
| Abigail P. Johnson | Individual | 6.60% | 9,307,349 | Nov 5, 2026 | 13D/G |
| Vanguard Capital Management | Investment adviser | 5.05% | 7,081,293 | Apr 29, 2026 | 13D/G |
| State Street Corporation | Holding company | 4.60% | 6,371,056 | Aug 11, 2025 | 13D/G |
| Vanguard Portfolio Management | Investment adviser | 4.53% | 6,384,903 | Jul 31, 2026 | 13D/G |
Insider Trades (100)
Last 4 quarters: 523,341 acquired · 637,527 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| OLUKOTUN ADEOYE Y | director | Aug 18, 2026 | SELL | 2,000 | $86.96 | $173.9K | Form 4 |
| PERRY MICHAEL S | director | Aug 18, 2026 | SELL | 11,600 | $87.30 | $1.0M | Form 4 |
| Cohen Matthew Gregory | director | Jun 15, 2026 | AWARD | 11,882 | — | — | Form 4 |
| Cohen Matthew Gregory | director | Jun 15, 2026 | OTHER | 0 | — | — | Form 4 |
| Lu Hongbo | director | May 12, 2026 | SELL | 2,970 | $76.88 | $228.3K | Form 4 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22, 2026 | SELL | 3,208 | $70.11 | $224.9K | Form 4 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22, 2026 | SELL | 1,157 | $70.45 | $81.5K | Form 4 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 22, 2026 | SELL | 8,730 | $71.92 | $627.9K | Form 4 |
| Hamilton James C | Chief Medical Officer | Apr 23, 2026 | SELL | 10,000 | $75.00 | $750.0K | Form 4 |
| Hamilton James C | Chief Medical Officer | Mar 5, 2026 | SELL | 10,000 | $64.19 | $641.9K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 6, 2026 | AWARD | 75,000 | — | — | Form 4 |
| Apel Daniel Joseph | Chief Financial Officer | Jan 6, 2026 | AWARD | 75,000 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | AWARD | 75,000 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | GIFT | 540 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | GIFT | 540 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | GIFT | 540 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | GIFT | 440 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 6, 2026 | GIFT | 440 | — | — | Form 4 |
| O'Brien Patrick | COO | Dec 31, 2025 | GIFT | 560 | — | — | Form 4 |
| O'Brien Patrick | COO | Dec 31, 2025 | GIFT | 560 | — | — | Form 4 |
| O'Brien Patrick | COO | Dec 31, 2025 | GIFT | 560 | — | — | Form 4 |
| O'Brien Patrick | COO | Dec 31, 2025 | GIFT | 560 | — | — | Form 4 |
| O'Brien Patrick | COO | Dec 31, 2025 | GIFT | 560 | — | — | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 4,368 | $61.20 | $267.3K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 6,164 | $62.23 | $383.6K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 13,451 | $62.96 | $846.9K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 11,842 | $63.84 | $756.0K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 2,700 | $64.44 | $174.0K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 900 | $66.01 | $59.4K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 313 | $68.00 | $21.3K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 600 | $61.12 | $36.7K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 900 | $62.25 | $56.0K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 5,873 | $62.91 | $369.5K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 2,336 | $64.04 | $149.6K | Form 4 |
| O'Brien Patrick | COO | Jan 5, 2026 | SELL | 46 | $68.00 | $3.1K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 4,625 | $61.24 | $283.2K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 6,090 | $62.28 | $379.3K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 14,792 | $63.01 | $932.0K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 12,711 | $63.95 | $812.9K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 1,200 | $64.49 | $77.4K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 437 | $65.97 | $28.8K | Form 4 |
| Hamilton James C | Chief Medical Officer | Jan 5, 2026 | SELL | 309 | $68.00 | $21.0K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Jan 2, 2026 | SELL | 7,416 | $65.88 | $488.6K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Jan 2, 2026 | SELL | 5,771 | $66.39 | $383.1K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | OPTION EX. | 16,545 | $6.15 | $101.8K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | OPTION EX. | 35,181 | $6.15 | $216.4K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | SELL | 35,181 | $69.33 | $2.4M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | SELL | 16,545 | $68.69 | $1.1M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | OPTION EX. | 35,181 | $6.15 | $216.4K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 29, 2025 | OPTION EX. | 16,545 | $6.15 | $101.8K | Form 4 |
| Ferrari Mauro | director | Dec 26, 2025 | SELL | 7,530 | $70.00 | $527.1K | Form 4 |
| Waddill William D. | director | Dec 19, 2025 | SELL | 2,416 | $66.66 | $161.1K | Form 4 |
| Waddill William D. | director | Dec 19, 2025 | SELL | 5,451 | $68.01 | $370.7K | Form 4 |
| Waddill William D. | director | Dec 19, 2025 | SELL | 500 | $68.53 | $34.3K | Form 4 |
| Vakiener Victoria | director | Dec 19, 2025 | SELL | 2,799 | $66.63 | $186.5K | Form 4 |
| Vakiener Victoria | director | Dec 19, 2025 | SELL | 5,281 | $67.97 | $358.9K | Form 4 |
| Vakiener Victoria | director | Dec 19, 2025 | SELL | 1,960 | $68.39 | $134.0K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 19, 2025 | SELL | 3,979 | $66.67 | $265.3K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 19, 2025 | SELL | 8,147 | $68.01 | $554.1K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 19, 2025 | SELL | 1,319 | $68.48 | $90.3K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 22, 2025 | SELL | 10,012 | $68.33 | $684.1K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 22, 2025 | SELL | 2,574 | $68.85 | $177.2K | Form 4 |
| OLUKOTUN ADEOYE Y | director | Dec 19, 2025 | SELL | 3,090 | $66.70 | $206.1K | Form 4 |
| OLUKOTUN ADEOYE Y | director | Dec 19, 2025 | SELL | 6,083 | $68.04 | $413.9K | Form 4 |
| OLUKOTUN ADEOYE Y | director | Dec 19, 2025 | SELL | 827 | $68.48 | $56.6K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 17, 2025 | SELL | 46,287 | $63.55 | $2.9M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 17, 2025 | SELL | 35,750 | $64.51 | $2.3M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 17, 2025 | SELL | 982 | $65.53 | $64.4K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 17, 2025 | SELL | 1,981 | $66.30 | $131.3K | Form 4 |
| Ferrari Mauro | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| Lu Hongbo | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| PERRY MICHAEL S | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| Vakiener Victoria | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| INGRAM DOUGLAS S | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| OLUKOTUN ADEOYE Y | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| Waddill William D. | director | Dec 16, 2025 | AWARD | 7,819 | — | — | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 12, 2025 | AWARD | 180,000 | — | — | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 15, 2025 | SELL | 100,532 | $68.67 | $6.9M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 15, 2025 | SELL | 21,321 | $69.28 | $1.5M | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 15, 2025 | SELL | 8,147 | $69.96 | $570.0K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 8,416 | $60.51 | $509.3K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 10,963 | $61.25 | $671.5K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 14,095 | $62.12 | $875.6K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 8,476 | $62.94 | $533.5K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 6,661 | $64.29 | $428.2K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 1,000 | $64.96 | $65.0K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 1,300 | $65.77 | $85.5K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 166 | $66.77 | $11.1K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Dec 16, 2025 | SELL | 3,221 | $67.87 | $218.6K | Form 4 |
| PERRY MICHAEL S | director | Dec 5, 2025 | SELL | 16,250 | $61.03 | $991.7K | Form 4 |
| Ferrari Mauro | director | Nov 28, 2025 | SELL | 8,750 | $56.39 | $493.4K | Form 4 |
| Hamilton James C | Chief Medical Officer | Oct 1, 2025 | SELL | 20,000 | $35.00 | $700.0K | Form 4 |
| Hamilton James C | Chief Medical Officer | Sep 12, 2025 | SELL | 15,000 | $30.00 | $450.0K | Form 4 |
| Hamilton James C | Chief Medical Officer | Sep 2, 2025 | SELL | 15,000 | $25.00 | $375.0K | Form 4 |
| Hamilton James C | Chief Medical Officer | Aug 13, 2025 | SELL | 611 | $20.00 | $12.2K | Form 4 |
| Hamilton James C | Chief Medical Officer | Aug 15, 2025 | SELL | 9,389 | $20.00 | $187.8K | Form 4 |
| Apel Daniel Joseph | Chief Financial Officer | Apr 15, 2025 | OTHER | 0 | — | — | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Apr 9, 2025 | SELL | 35,305 | $9.93 | $350.6K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Apr 9, 2025 | SELL | 3,400 | $10.75 | $36.5K | Form 4 |
| Anzalone Christopher Richard | director, officer: Chief Executive Officer | Apr 9, 2025 | SELL | 1,617 | $11.76 | $19.0K | Form 4 |
Congress & Senate Trades (1)
Daniel GoldmanHouse · NY10Jan 31, 2023